Acri Capital Acquisition Corporation
(NASDAQ: ACAC) |
$11.190 |
$60.61M |
0% |
Acrivon Therapeutics Inc.
(NASDAQ: ACRV) |
$10.089 |
$311.50M |
+19.27% |
Actelis Networks Inc.
(NASDAQ: ASNS) |
$0.790 |
$2.27M |
-3.72% |
Actinium Pharmaceuticals Inc.
(NYSE American: ATNM) |
$7.370 |
$216.65M |
+7.28% |
Acumen Pharmaceuticals Inc.
(NASDAQ: ABOS) |
$3.285 |
$197.36M |
+4.73% |
Acurx Pharmaceuticals Inc.
(NASDAQ: ACXP) |
$2.080 |
$32.46M |
0% |
Acutus Medical Inc.
(NASDAQ: AFIB) |
$0.163 |
$4.82M |
-2.40% |
Adagene Inc.
(NASDAQ: ADAG) |
$2.325 |
$100.24M |
-1.67% |
Adamas One Corp.
(NASDAQ: JEWL) |
$0.295 |
$8.26M |
-4.95% |
Adams Resources & Energy Inc.
(NYSE American: AE) |
$29.500 |
$76.87M |
0% |
Adaptimmune Therapeutics
(NASDAQ: ADAP) |
$1.175 |
$299.01M |
+8.84% |
Addentax Group Corp.
(NASDAQ: ATXG) |
$1.044 |
$4.47M |
0% |
Addex Therapeutics Ltd
(NASDAQ: ADXN) |
$8.100 |
$8.67M |
-50.25% |
Adial Pharmaceuticals Inc
(NASDAQ: ADIL) |
$1.684 |
$6.81M |
+5.90% |
Adicet Bio Inc.
(NASDAQ: ACET) |
$1.645 |
$134.76M |
-2.08% |
Aditxt Inc.
(NASDAQ: ADTX) |
$2.460 |
$4.05M |
0% |
Adlai Nortye Ltd.
(NASDAQ: ANL) |
$14.329 |
$514.76M |
0% |
AdTheorent Holding Company Inc.
(NASDAQ: ADTH) |
$3.255 |
$299.50M |
0% |
Advent Technologies Holdings Inc.
(NASDAQ: ADN) |
$0.146 |
$11.13M |
-2.64% |
Adverum Biotechnologies Inc.
(NASDAQ: ADVM) |
$9.525 |
$197.69M |
+3.37% |